Reporting owner · Q3 2026 · CIK 1859484

Tomkiel Melissa M.: insider trades.

Tomkiel Melissa M. reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
0
Companies
1
Name as filed
Tomkiel Melissa M.

Companies

CompanyRelationshipTransactions
Strata Critical Medical, Inc. (SRTA)Director, Officer · Co-CEO and General Counsel6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-24Strata Critical Medical, Inc.F90,797$5.272,153,678Form 4
2026-09-24Strata Critical Medical, Inc.A177,858$02,244,475Form 4
2026-09-08Strata Critical Medical, Inc.F29,730$5.312,066,617Form 4
2026-07-31Strata Critical Medical, Inc.F212,309$5.092,096,347Form 4
2026-07-30Strata Critical Medical, Inc.A206,953$02,308,656Form 4
2026-07-30Strata Critical Medical, Inc.A208,929$02,101,703Form 4

Questions

What stock did Tomkiel Melissa M. buy or sell?

Tomkiel Melissa M. reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Is Tomkiel Melissa M. the same person as other filers with this name?

This page covers SEC CIK 1859484 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/tomkiel-melissa-m-1859484.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.